Home/Filings/4/0001493152-22-002556
4//SEC Filing

Newman Michael James 4

Accession 0001493152-22-002556

CIK 0001857044other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 4:31 PM ET

Size

5.5 KB

Accession

0001493152-22-002556

Insider Transaction Report

Form 4
Period: 2022-01-26
Newman Michael James
DirectorCSO and Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-26+43,35043,350 total
    Exercise: $4.90Exp: 2032-01-26Common Stock (43,350 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.

Documents

1 file

Issuer

Indaptus Therapeutics, Inc.

CIK 0001857044

Entity typeother

Related Parties

1
  • filerCIK 0001876315

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:31 PM ET
Size
5.5 KB